News
Novo Nordisk A/S is selling its blockbuster weight-loss drug Wegovy to new patients at $199 for the first month as easy ...
Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...
Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...
Novo Nordisk said on Thursday it is offering self-paying patients who are new to its weight loss drug Wegovy their first ...
Comedy legend George Wendt has sadly passed away at the age of 76. Known to generations of fans as Norm from Cheers, Wendt's ...
The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...
The new weight-loss option will cut what the plan sponsors pay as well as what the patients pay, Cigna’s PBM Evernorth says.
As the FDA’s ban on mass compounding of semaglutide takes effect, Novo Nordisk introduces discounted pricing and new patient ...
When considering a weight loss medication — or any medication — it’s normal to wonder when the effects will kick in.
Novo Nordisk (NVO) stock in focus as the company promotes FDA-approved Wegovy as a ban for makers of compounding versions ...
It's plainly apparent that Novo Nordisk has had May 22 circled its calendar since February, when the FDA began the countdown ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results